Avant Diagnostics Inc (AVDX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Employees:
217 PERRY PARKWAY, SUITE 8, GAITHERSBURG, MD 20877
(732) 410-9810

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 6.892 Million Shares Outstanding215.36 Million Avg 30-day Volume 38.743 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.01
Price to Revenue0.0 Debt to Equity0.0264 EBITDA-833.991 Thousand
Price to Book Value1.5111 Operating Margin0.0 Enterprise Value3.512 Million
Current Ratio0.1 EPS Growth0 Quick Ratio0.1
1 Yr BETA -2.0935 52-week High/Low 0.0 / Profit Margin0.0
Operating Cash Flow Growth-894.4356 Altman Z-Score-9.4409 Free Cash Flow to Firm -1.381 Million

Are you looking for this stock instead?

View SEC Filings from AVDX instead.

View recent insider trading info

Funds Holding AVDX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AVDX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HAUSMAN JAMES E

  • Director
819,784 2021-10-12 1

MORRIS NIGEL W

  • Director
0 2021-10-12 1

BAIN CAPITAL VENTURE INVESTORS, LLC

BAIN CAPITAL VENTURE COINVESTMENT FUND, L.P.

BAIN CAPITAL VENTURE COINVESTMENT PARTNERS, L.P.

BAIN CAPITAL VENTURE FUND 2014, L.P.

BAIN CAPITAL VENTURE PARTNERS 2014, L.P.

BCV AX INVESTORS, L.P.

BCIP VENTURE ASSOCIATES

BCIP VENTURE ASSOCIATES-B

SALEM ENRIQUE T

AGARWAL AJAY

  • 10% Owner
0 2021-10-12 1

MORRIS JOHN C.

  • Director
0 2021-10-12 1

HARRIS MATTHEW C

  • Director
  • 10% Owner
0 2021-10-12 1

DRUMMOND LANCE F.

  • Director
0 2021-10-12 1

MURDOCK WENDY J.

  • Director
0 2021-10-12 1

MCGUIRE JAMES MICHAEL

  • Director
0 2021-10-12 1

PRAEGER MICHAEL SEE REMARKS

  • Officer
  • Director
11,505,348 2021-10-12 1

STAHL RYAN SEE REMARKS

  • Officer
96,008 2021-10-12 1

GIBSON ANGELIC SEE REMARKS

  • Officer
0 2021-10-12 1

MACKINTOSH TERESA

  • Director
0 2021-10-12 1

DREES DANIEL SEE REMARKS

  • Officer
92,265 2021-10-12 1

CUNNINGHAM TODD ALAN SEE REMARKS

  • Officer
0 2021-10-12 1

WILHITE JOEL SEE REMARKS

  • Officer
0 2021-10-12 1

SHROTRIYA RAJESH C MD

  • Director
0 2018-08-28 0

DELAO ANDREW JOHN

  • Director
0 2018-08-28 0

RUXIN MICHAEL I CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2018-08-23 0

BUSCH JEFFREY

  • Director
0 2018-08-20 0

COLE HENRY

  • Director
0 2018-06-09 0

BRUGMANN JOHN EDWARD

  • Director
0 2018-05-25 0

TRAPP ROBERT H

  • Director
0 2017-11-07 0

INFUSION 51A, L.P.

STEPHENS JEFFREY

VANDERMEER SCOTT

  • Director
  • 10% Owner
11,283,333 2017-08-09 0

INFUSION 51A, L.P.

  • 10% Owner
13,283,333 2017-06-19 0

STEPHENS JEFFREY

  • Director
  • 10% Owner
17,358,333 2017-06-19 0

VANDERMEER SCOTT

  • 10% Owner
17,358,333 2017-06-19 0

SCOTT STEVEN EUGENE

  • 10% Owner
15,241,176 2015-04-10 0

PLUMB STEVEN M CHIEF FINANCIAL OFFICER

  • Officer
  • Director
  • 10% Owner
34,000,000 2014-12-29 0

DELTA S VENTURES, LP CHAIRMAN

  • Officer
  • Director
  • 10% Owner
34,000,000 2014-12-29 0

VOLLMERS ALVARO SEE REMARKS

  • Officer
  • Director
  • 10% Owner
150,000 2010-05-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 15:15:03 UTC -0.18 0.25 3000
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 14:45:02 UTC -0.18 0.25 20000
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 14:15:03 UTC -0.18 0.25 20000
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 13:45:03 UTC -0.18 0.25 20000
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 13:15:03 UTC -0.18 0.25 20000
AVIDXCHANGE HOLDINGS INC AVDX 2021-10-15 12:45:03 UTC -0.18 0.25 20000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments